Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 817

1.

Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck Cancer.

Cao Y, Aryal M, Li P, Lee C, Schipper M, Hawkins PG, Chapman C, Owen D, Dragovic AF, Swiecicki P, Casper K, Worden F, Lawrence TS, Eisbruch A, Mierzwa M.

Front Oncol. 2019 Nov 14;9:1118. doi: 10.3389/fonc.2019.01118. eCollection 2019.

2.

Cycling related major trauma in Ireland.

Foley J, Cronin M, Brent L, Lawrence T, Simms C, Gildea K, Ryan J, Deasy C, Cronin J.

Injury. 2019 Nov 20. pii: S0020-1383(19)30746-6. doi: 10.1016/j.injury.2019.11.025. [Epub ahead of print]

PMID:
31784058
3.

Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson L, Karasic T, Llovet J, Finn R, Groopman J, El-Serag H, Monga S, Wang XW, Karin M, Schwartz R, Tanabe K, Roberts L, Gunaratne P, Tsung A, Brown K, Lawrence T, Salem R, Singal A, Kim A, Rabiee A, Resar L, Meyer J, Hoshida Y, He AR, Ghoshal K, Ryan P, Jaffee E, Guha C, Mishra L, Coleman N, Ahmed M.

Cancer Res. 2019 Nov 15;79(22):5897. doi: 10.1158/0008-5472.CAN-19-2958. No abstract available.

PMID:
31772073
4.

Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.

Verdeil G, Lawrence T, Schmitt-Verhulst AM, Auphan-Anezin N.

Cancers (Basel). 2019 Nov 21;11(12). pii: E1832. doi: 10.3390/cancers11121832. Review.

5.

A Pilot Study of Atezolizumab plus Hypofractionated Image-guided Radiotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer.

Qin A, Rengan R, Lee S, Santana-Davila R, Goulart BHL, Martins R, Baik C, Kalemkerian GP, Hassan KA, Schneider BJ, Hayman JA, Jolly S, Hearn J, Lawrence TS, Towlerton AMH, Tewari M, Thomas D, Zhao L, Brown N, Frankel TL, Warren EH, Ramnath N.

Int J Radiat Oncol Biol Phys. 2019 Nov 19. pii: S0360-3016(19)34007-6. doi: 10.1016/j.ijrobp.2019.10.047. [Epub ahead of print]

PMID:
31756415
6.

Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice.

Tilstam PV, Soppert J, Hemmers C, Harlacher E, Döring Y, van der Vorst EPC, Schulte C, Alampour-Rajabi S, Theelen W, Asare Y, de Winther MPJ, Lawrence T, Bernhagen J, Schober A, Zernecke A, Jankowski J, Weber C, Noels H.

Atherosclerosis. 2019 Nov 2;292:23-30. doi: 10.1016/j.atherosclerosis.2019.10.023. [Epub ahead of print]

PMID:
31733453
7.

Impediments to Optimal Health-care Utilization of a Particularly Vulnerable Tribal Group in Wayanad: A Qualitative Study.

Moosan H, Stanley A, Vijayakumar K, Jayasree AK, Lawrence T, Veena A.

Indian J Community Med. 2019 Oct;44(Suppl 1):S62-S65. doi: 10.4103/ijcm.IJCM_48_19.

8.

Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

Ray D, Ray P, Ferrer-Torres D, Wang Z, Nancarrow D, Yoon HW, San Martinho M, Hinton T, Owens S, Thomas D, Jiang H, Lawrence TS, Lin J, Lagisetty K, Chang AC, Beer DG.

Gastroenterology. 2019 Nov 9. pii: S0016-5085(19)41531-X. doi: 10.1053/j.gastro.2019.10.040. [Epub ahead of print]

PMID:
31715145
9.

Epidemiology of adult rib fracture and factors associated with surgical fixation: Analysis of a chest wall injury dataset from England and Wales.

Ingoe HM, Eardley W, McDaid C, Rangan A, Lawrence T, Hewitt C.

Injury. 2019 Oct 15. pii: S0020-1383(19)30631-X. doi: 10.1016/j.injury.2019.10.030. [Epub ahead of print]

PMID:
31690496
10.

Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.

Cole MJ, Tan W, Fifer H, Brittain C, Duley L, Hepburn T, Lawrence T, Montgomery AA, Sprange K, Thandi S, Churchward C, Tripodo F, Woodford N, Ross JDC.

J Antimicrob Chemother. 2019 Oct 31. pii: dkz436. doi: 10.1093/jac/dkz436. [Epub ahead of print]

PMID:
31670808
11.

Tracking Dynamics of Spontaneous Tumors in Mice Using Photon-Counting Computed Tomography.

Cassol F, Portal L, Richelme S, Dupont M, Boursier Y, Arechederra M, Auphan-Anezin N, Chasson L, Laprie C, Fernandez S, Balasse L, Lamballe F, Dono R, Guillet B, Lawrence T, Morel C, Maina F.

iScience. 2019 Nov 22;21:68-83. doi: 10.1016/j.isci.2019.10.015. Epub 2019 Oct 9.

12.

The three members of the Vav family proteins form complexes that concur to foam cell formation and atherosclerosis.

Huang R, Guo G, Lu L, Fu R, Luo J, Liu Z, Gu Y, Yang W, Zheng Q, Chao T, He L, Wang Y, Niu Z, Wang H, Lawrence T, Malissen M, Malissen B, Liang Y, Zhang L.

J Lipid Res. 2019 Dec;60(12):2006-2019. doi: 10.1194/jlr.M094771. Epub 2019 Sep 30.

PMID:
31570505
13.

Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11.

Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, Saripalli AL, Kryczek I, Wei S, Szeliga W, Vatan L, Stone EM, Georgiou G, Cieslik M, Wahl DR, Morgan MA, Chinnaiyan AM, Lawrence TS, Zou W.

Cancer Discov. 2019 Dec;9(12):1673-1685. doi: 10.1158/2159-8290.CD-19-0338. Epub 2019 Sep 25.

14.

Acticoat versus biobrane: a retrospective review on the treatment of paediatric mid-dermal torso burns.

Selvarajah D, Bollu BK, Harvey J, Jacques M, Jehangir S, Fuller ES, La Hei E, Bertinetti M, Lawrence T, Holland AJ.

Int J Burns Trauma. 2019 Aug 15;9(4):82-87. eCollection 2019.

15.

Phase II trial of neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer.

Tran NH, Sahai V, Griffith KA, Nathan H, Kaza R, Cuneo KC, Shi J, Kim E, Sonnenday CJ, Cho CS, Lawrence TS, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2019 Sep 5. pii: S0360-3016(19)33746-0. doi: 10.1016/j.ijrobp.2019.08.057. [Epub ahead of print]

PMID:
31494181
16.

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.

Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM.

Cancer Res. 2019 Sep 1;79(17):4326-4330. doi: 10.1158/0008-5472.CAN-19-0803. Erratum in: Cancer Res. 2019 Nov 15;79(22):5897.

PMID:
31481419
17.

A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.

Jackson WC, Suresh K, Maurino C, Feng M, Cuneo KC, Ten Haken RK, Lawrence TS, Schipper MJ, Owen D.

Radiother Oncol. 2019 Dec;141:101-107. doi: 10.1016/j.radonc.2019.07.027. Epub 2019 Aug 17.

PMID:
31431377
18.

Good Health and Wellness: Measuring Impact Through an Indigenous Lens.

Lawrence TJ, James RD.

Prev Chronic Dis. 2019 Aug 15;16:E108. doi: 10.5888/pcd16.180655.

19.

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer.

Cuneo KC, Morgan MA, Sahai V, Schipper MJ, Parsels LA, Parsels JD, Devasia T, Al-Hawaray M, Cho CS, Nathan H, Maybaum J, Zalupski MM, Lawrence TS.

J Clin Oncol. 2019 Oct 10;37(29):2643-2650. doi: 10.1200/JCO.19.00730. Epub 2019 Aug 9.

PMID:
31398082
20.

Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.

Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, Moulin M, Bosenberg M, Graversen JH, Auphan-Anezin N, Moestrup SK, Lawrence T.

J Exp Med. 2019 Oct 7;216(10):2394-2411. doi: 10.1084/jem.20182124. Epub 2019 Aug 2.

PMID:
31375534
21.

Changing the System - Major Trauma Patients and Their Outcomes in the NHS (England) 2008-17.

Moran CG, Lecky F, Bouamra O, Lawrence T, Edwards A, Woodford M, Willett K, Coats TJ.

EClinicalMedicine. 2018 Aug 5;2-3:13-21. doi: 10.1016/j.eclinm.2018.07.001. eCollection 2018 Aug-Sep.

22.

In Reply to Slovak et al.

Jackson WC, Cuneo KC, Lawrence TS, Owen D.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):696-697. doi: 10.1016/j.ijrobp.2019.03.006. No abstract available.

PMID:
31162061
23.

Xenograft-based platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma.

Zhao SG, Yu M, Spratt DE, Chang SL, Feng FY, Kim MM, Speers CW, Carlson BL, Mladek AC, Lawrence TS, Sarkaria JN, Wahl DR.

Neuro Oncol. 2019 May 23. pii: noz090. doi: 10.1093/neuonc/noz090. [Epub ahead of print]

PMID:
31121035
24.

Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.

Zhang Q, Green MD, Lang X, Lazarus J, Parsels JD, Wei S, Parsels LA, Shi J, Ramnath N, Wahl DR, Pasca di Magliano M, Frankel TL, Kryczek I, Lei YL, Lawrence TS, Zou W, Morgan MA.

Cancer Res. 2019 Aug 1;79(15):3940-3951. doi: 10.1158/0008-5472.CAN-19-0761. Epub 2019 May 17.

PMID:
31101760
25.

Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.

Ross JD, Harding J, Duley L, Montgomery AA, Hepburn T, Tan W, Brittain C, Meakin G, Sprange K, Thandi S, Jackson L, Roberts T, Wilson J, White J, Dewsnap C, Cole M, Lawrence T.

Health Technol Assess. 2019 May;23(20):1-104. doi: 10.3310/hta23200.

26.

Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury.

Cuneo KC, Devasia T, Sun Y, Schipper MJ, Karnak D, Davis MA, Owen D, Feng M, El Naqa I, Bazzi L, Ten Haken R, Lawrence TS.

Transl Oncol. 2019 Jul;12(7):889-894. doi: 10.1016/j.tranon.2019.04.003. Epub 2019 May 9.

27.

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.

Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T, Jackson L, Keogh M, Lawrence T, Montgomery AA, Roberts TE, Sprange K, Tan W, Thandi S, White J, Wilson J, Duley L; G-ToG trial team.

Lancet. 2019 Jun 22;393(10190):2511-2520. doi: 10.1016/S0140-6736(18)32817-4. Epub 2019 May 2. Erratum in: Lancet. 2019 Jun 29;393(10191):2590. Lancet. 2019 Jun 20;:. Lancet. 2019 Oct 5;394(10205):1230.

28.

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy.

Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, Wei S, Vatan L, Zhang H, Szeliga W, Gu W, Liu R, Lawrence TS, Lamb C, Tanno Y, Cieslik M, Stone E, Georgiou G, Chan TA, Chinnaiyan A, Zou W.

Nature. 2019 May;569(7755):270-274. doi: 10.1038/s41586-019-1170-y. Epub 2019 May 1.

29.

Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.

Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence TS, Tsien CI.

J Neurooncol. 2019 Jun;143(2):313-319. doi: 10.1007/s11060-019-03166-3. Epub 2019 Apr 11.

PMID:
30977058
30.

Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.

Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, Ulas T, Papantonopoulou O, Van Eck M, Auphan-Anezin N, Bebien M, Verthuy C, Vu Manh TP, Turner M, Dalod M, Schultze JL, Lawrence T.

Cell Metab. 2019 Jun 4;29(6):1376-1389.e4. doi: 10.1016/j.cmet.2019.02.016. Epub 2019 Mar 28.

PMID:
30930171
31.

Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.

Hawkins PG, Sun Y, Dess RT, Jackson WC, Sun G, Bi N, Tewari M, Hayman JA, Kalemkerian GP, Gadgeel SM, Lawrence TS, Haken RKT, Matuszak MM, Kong FS, Schipper MJ, Jolly S.

J Cancer Res Clin Oncol. 2019 Jun;145(6):1635-1643. doi: 10.1007/s00432-019-02903-5. Epub 2019 Mar 28.

PMID:
30923943
32.

Development of a Fully Cross-Validated Bayesian Network Approach for Local Control Prediction in Lung Cancer.

Luo Y, McShan D, Ray D, Matuszak M, Jolly S, Lawrence T, Ming Kong F, Ten Haken R, El Naqa I.

IEEE Trans Radiat Plasma Med Sci. 2019 Mar;3(2):232-241. doi: 10.1109/TRPMS.2018.2832609. Epub 2018 May 2.

PMID:
30854500
33.

Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.

Kim MM, Parmar HA, Aryal MP, Mayo CS, Balter JM, Lawrence TS, Cao Y.

Tomography. 2019 Mar;5(1):118-126. doi: 10.18383/j.tom.2018.00035.

34.

MRS and DTI evidence of progressive posterior cingulate cortex and corpus callosum injury in the hyper-acute phase after Traumatic Brain Injury.

Lawrence TP, Steel A, Ezra M, Speirs M, Pretorius PM, Douaud G, Sotiropoulos S, Cadoux-Hudson T, Emir UE, Voets NL.

Brain Inj. 2019;33(7):854-868. doi: 10.1080/02699052.2019.1584332. Epub 2019 Mar 8.

35.

Precise and Rapid Validation of Candidate Gene by Allele Specific Knockout With CRISPR/Cas9 in Wild Mice.

Chao T, Liu Z, Zhang Y, Zhang L, Huang R, He L, Gu Y, Chen Z, Zheng Q, Shi L, Zheng W, Qi X, Kong E, Zhang Z, Lawrence T, Liang Y, Lu L.

Front Genet. 2019 Feb 19;10:124. doi: 10.3389/fgene.2019.00124. eCollection 2019.

36.

Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.

Kamarajah SK, Sonnenday CJ, Cho CS, Frankel TL, Bednar F, Lawrence TS, Nathan H.

Ann Surg. 2019 Feb 25. doi: 10.1097/SLA.0000000000003242. [Epub ahead of print]

PMID:
30817352
37.

The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.

Zhang Q, Mady ASA, Ma Y, Ryan C, Lawrence TS, Nikolovska-Coleska Z, Sun Y, Morgan MA.

Nucleic Acids Res. 2019 May 7;47(8):4039-4053. doi: 10.1093/nar/gkz058.

38.

PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer.

Wang Y, Kim TH, Fouladdel S, Zhang Z, Soni P, Qin A, Zhao L, Azizi E, Lawrence TS, Ramnath N, Cuneo KC, Nagrath S.

Sci Rep. 2019 Jan 24;9(1):566. doi: 10.1038/s41598-018-36096-7.

39.

Socioeconomic status and 30-day mortality after minor and major trauma: A retrospective analysis of the Trauma Audit and Research Network (TARN) dataset for England.

McHale P, Hungerford D, Taylor-Robinson D, Lawrence T, Astles T, Morton B.

PLoS One. 2018 Dec 31;13(12):e0210226. doi: 10.1371/journal.pone.0210226. eCollection 2018.

40.

Clinical Development of Novel Drug-Radiotherapy Combinations.

Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, Baird RD, Williams KJ, Illidge T, Hahn SM, Lawrence TS, Spears PA, Walker AJ, Sharma RA.

Clin Cancer Res. 2019 Mar 1;25(5):1455-1461. doi: 10.1158/1078-0432.CCR-18-2466. Epub 2018 Nov 29.

PMID:
30498095
41.

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib.

Cuneo KC, Mehta RK, Kurapati H, Thomas DG, Lawrence TS, Nyati MK.

Transl Oncol. 2019 Feb;12(2):209-216. doi: 10.1016/j.tranon.2018.10.005. Epub 2018 Nov 6.

42.

Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.

Kong FS, Li L, Wang W, Campbell J, Waller JL, Piert M, Gross M, Cheng M, Owen D, Stenmark M, Huang KC, Frey KA, Ten Haken RK, Lawrence TS.

Radiother Oncol. 2019 Mar;132:241-249. doi: 10.1016/j.radonc.2018.10.006. Epub 2018 Oct 30.

PMID:
30389239
43.

Significance of Perioperative Tests to Diagnose the Infection in Revision Total Shoulder Arthroplasty.

Ahmadi S, Lawrence TM, Sahota S, Schleck CD, Harmsen WS, Cofield RH, Sperling JW.

Arch Bone Jt Surg. 2018 Sep;6(5):359-364.

44.

Treatment data and technical process challenges for practical big data efforts in radiation oncology.

Mayo CS, Phillips M, McNutt TR, Palta J, Dekker A, Miller RC, Xiao Y, Moran JM, Matuszak MM, Gabriel P, Ayan AS, Prisciandaro J, Thor M, Dixit N, Popple R, Killoran J, Kaleba E, Kantor M, Ruan D, Kapoor R, Kessler ML, Lawrence TS.

Med Phys. 2018 Oct;45(10):e793-e810. doi: 10.1002/mp.13114. Epub 2018 Sep 18.

PMID:
30226286
45.

Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.

Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino C, Cuneo KC, Lawrence TS, Owen D.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):169-179. doi: 10.1016/j.ijrobp.2018.09.004. Epub 2018 Sep 10.

PMID:
30213751
46.

Acetabular Subchondral Bone Decortication and Its Role in the Outcome of Cemented Total Hip Replacement in Young Patients.

Garala K, Boutefnouchet T, Amblawaner K, Chahal G, Lawrence T.

Hip Pelvis. 2018 Sep;30(3):182-189. doi: 10.5371/hp.2018.30.3.182. Epub 2018 Sep 4.

47.

No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine Kinases.

Wahl DR, Lawrence TS.

Clin Cancer Res. 2019 Jan 15;25(2):455-456. doi: 10.1158/1078-0432.CCR-18-2113. Epub 2018 Sep 4.

PMID:
30181388
48.

Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection.

Tomasello E, Naciri K, Chelbi R, Bessou G, Fries A, Gressier E, Abbas A, Pollet E, Pierre P, Lawrence T, Vu Manh TP, Dalod M.

EMBO J. 2018 Oct 1;37(19). pii: e98836. doi: 10.15252/embj.201798836. Epub 2018 Aug 21.

49.

Biobrane™ versus acticoat™ for the treatment of mid-dermal pediatric burns: a prospective randomized controlled pilot study.

Hyland EJ, D'Cruz R, Menon S, Harvey JG, La Hei E, Lawrence T, Waddell K, Nash M, Holland AJ.

Int J Burns Trauma. 2018 Jun 20;8(3):63-67. eCollection 2018.

50.

Spatially explicit action research for coastal fisheries management.

Lawrence TN, Bhalla RS.

PLoS One. 2018 Jul 11;13(7):e0199841. doi: 10.1371/journal.pone.0199841. eCollection 2018.

Supplemental Content

Loading ...
Support Center